Therapeutics Therapeutics Home Tools Email Share How would you like to share? Facebook Twitter LinkedIn Back to the Top Find a Therapeutic By Name Go RO7105705 AAB-003 AADvac-1 ABT 418 ABT-089 ABT-288 ABT-384 ABT-957 ABvac 40 Acetyl-l-carnitine HCI ACI-24 ACI-35 Acitretin Aducanumab AF 102B Affitope AD02 AGB101 Allopregnanolone Alpha-Tocopherol Alzhemed™ ALZT-OP1 AN-1792 Anavex 2-73 Aripiprazole Atabecestat Atomoxetine Atorvastatin Avagacestat AVP-786 AVP-923 AZD1446 AZD3480 Azeliragon BAN2401 Bapineuzumab Besipirdine HCl Bexarotene BI 1181181 BI 409306 BI 425809 BIIB054 BIIB076 BIIB080 BIIB092 Brexpiprazole C2N 8E12 CAD106 Carvedilol Celecoxib CERE-110 Cerebrolysin CHF 5074 Circadin Clioquinol COGNIShunt™ Continuous Positive Airway Pressure COR388 Crenezumab Curcumin CX516 Dapsone Davunetide Deep Brain Stimulation-fornix Dexpramipexole Dimebon DNL747 Docosahexaenoic acid (DHA) Donanemab Donepezil Edonerpic EHT 0202 Elayta Elenbecestat ELND005 Encenicline Epigallocatechin Gallate (EGCG) Epothilone D Eptastigmine Estrogen Etanercept EVP-0962 Exendin-4 Flurizan™ FRM-0334 G-CSF Galantamine Gammagard® Gamunex Gantenerumab GC 021109 Gemfibrozil GLN-1062 GM-CSF Leukine GRF6019 GSK239512 GSK2647544 GSK933776 HF0220 HTL0018318 Huperzine A Ibuprofen Idalopirdine Idebenone Intepirdine JNJ-63733657 Ketasyn Ladostigil Lanabecestat Leuprolide Linopirdine Liraglutide LMTM Lornoxicam Lu AF20513 LU25-109 Lumateperone LY2599666 LY2886721 LY3202626 LY3303560 LY3372993 Masitinib MEDI1814 Melatonin MEM 1003 Memantine Metrifonate Milameline Minocycline MK-7622 MKC-231 MSDC-0160 Naproxen Nasal Insulin Nefiracetam Neflamapimod Nelonicline Nelotanserin NeoTrofin Neramexane NGX267 NIC5-15 Nicotinamide Nilvadipine Nimodipine NS2330 Octagam®10% ORM-12741 PBT2 PF-05212377 PF-05251749 PF-06648671 PF-06751979 PF-06852231 Phenserine Physostigmine Salicylate Pimavanserin Pioglitazone Piromelatine Ponezumab PQ912 Prazosin Prednisone Propentofylline PRX-03140 PRX002 PXT864 Rember TM Repetitive Transcranial Magnetic Stimulation Resveratrol RG3487 RG7129 RG7345 Rilapladib Riluzole Rivastigmine Rofecoxib Rosiglitazone S 38093 S-Equol S47445 Sabeluzole SAR110894D SAR228810 Saracatinib SB 202026 Semagacestat Sembragiline SGS-742 Simvastatin Solanezumab Souvenaid ST101 Suritozole SUVN-502 SUVN-G3031 T3D-959 Tacrine Telmisartan Thalidomide Tideglusib TPI 287 Tricaprilin UB 311 UCB0107 Umibecestat Valproate Vanutide cridificar Varenicline Verubecestat VY-AADC Xaliproden XanamemTM Young Plasma Other Search By Attributes FDA Status Phase 0 Phase 1 Phase 1/2 Phase 2 Phase 2/3 Phase 3 Phase 4 Approved Inactive Discontinued Not Regulated Target Type alpha-synuclein Amyloid-Related Cholesterol Cholinergic System Inflammation Metals Other Other Neurotransmitters Tau Unknown Therapy Type Dietary Supplement DNA-based Immunotherapy (active) Immunotherapy (passive) Other Procedural Intervention RNA-based Small Molecule Condition Alzheimer's Disease Cerebral Amyloid Angiopathy Frontotemporal Dementia Mild Cognitive Impairment Parkinson's Disease Keyword 0 Therapeutics View Results Reset Search Results Name Synonyms FDA Status Company Target Type Therapy Type Approved For
